Given activation of the EGFR pathway in the chordoma PDX, we next evaluated the efficacy of small molecule EGFR inhibitors against a validated chordoma cell line U-CH 1, which has also been shown to have activated EGFR [11]. The gene discussed is EGFR; the disease is chordoma.